Prior to joining TurtleTree, Aletta was with MilliporeSigma for over 10 years. Her newest appointment was as R&D Director of the businesss Cultured Meat department. There, Aletta led a clinical and engineering group in creating advanced innovations for the production of cultured meat. She also simultaneously led service and product development. Informing this leadership role was her previous experience as MilliporeSigmas Head of Cell Therapy Bioprocessing, in which she crafted economical cell culture media and reagents for use in cellular therapeutic applications. Aletta got her PhD in Immunology and Neuroscience from the Boston University School of Medicine in 2007. Because then, she has actually attained numerous career turning points: Besides having established a xeno-free cell culture medium for mesenchymal stromal cell (MSC) expansion, she is likewise an editorial board member of Stem Cells Translational Medicine, a worldwide journal devoted to stem cell research study. Describing her transition from biopharmaceuticals to cellular agriculture, Aletta said: “Developing life-saving medications through restorative cell production innovations was profoundly satisfying. With cellular agriculture, the goal to better human health with varied and nutritious alternative protein sources creates the prospective to make a wider impact. Being at TurtleTree grants me a vital opportunity to improve our food system and advantage society on a worldwide scale.” As TurtleTrees CSO, Dr. Schnitzler will communicate TurtleTrees scientific interests to internal and external stakeholders. To tactically execute the businesss cellular agriculture innovation strategies, Aletta will likewise work closely with the management and clinical teams to line up the companys international R&D efforts. With her breadth of experience and networks within the bioprocessing market, Aletta is poised to protect top-tier knowledge and crucial partnerships for the advancement of TurtleTrees cultivated food production innovations. Sharing her excitement about Alettas new role at TurtleTree, Fengru Lin, CEO of TurtleTree stated: “Were exceptionally honored to have Aletta and her know-how in both cellular farming and therapeutics with us. Were thrilled to see her use her experience to creating development cycles that will kickstart our productization.” About TurtleTreeTurtleTree is a biotech company devoted to producing a new generation of nutrition– one thats better for the world, much better for the animals, and much better for individuals all over. Utilizing its proprietary, cell-based innovation, the business is creating better-for-you milk ingredients sustainably and cost effectively, with benefits that extend beyond the dining table and into the heart of humanity.
Prior to joining TurtleTree, Aletta was with MilliporeSigma for over 10 years. Explaining her transition from biopharmaceuticals to cellular farming, Aletta stated: “Developing life-saving medicines through healing cell manufacturing innovations was profoundly rewarding. To tactically carry out the businesss cellular agriculture development strategies, Aletta will also work closely with the management and clinical teams to align the companys international R&D efforts.
